The vaccine relies on the same mRNA technology used in Moderna’s Covid-19 vaccine. (Freepik pic)MONTREAL : Canada has authorised US pharmaceutical giant Moderna to begin clinical trials for a vaccine against the Bundibugyo strain of Ebola, the Canadian health ministry announced Tuesday. If the results are positive, the vaccine will advance to further clinical trials involving larger groups of participants. The vaccine relies on the same mRNA technology used in Moderna’s Covid-19 vaccine. Treatments are also undergoing clinical trials in line with recommendations from the WHO.